Gliclazide hydroxylation by rat liver microsomes

References

• Back D. J., Sutcliffe F., Tija J. F. Tolbutamide as a model drug for the study of enzyme induction and enzyme inhibition in the rat. British Journal of Pharmacology 1984; 81: 557–562
   PubMed Web of Science ®Google Scholar
• Back D. J., Tija J. F., Karbwang J., Colbert J. In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines. British Journal of Clinical Pharmacology 1988; 26: 23–29
   PubMed Web of Science ®Google Scholar
• Bélanger P. M., St-Hilaire S. The characteristics of the microsomal hydroxylation of tolbutamide. Canadian Journal of Physiology and Pharmacology 1991; 69: 400–405
   PubMed Web of Science ®Google Scholar
• Campbell D. B., Adriaenssens P., Hopkins Y. W., Gordon B., Williams J. R. B. Pharmacokinetics and metabolism of gliclazide: a review. Proceedings of the Royal Society of Medicine International Congress and Symposium Series, Keen, et al. Academic Press and Royal Society of Medicine, London 1980; 20: 71–92
   Google Scholar
• Cornish-Bowden A. A simple graphical method for determining the inhibition constants of mixed uncompetitive and non-competitive inhibitors. Biochemical Journal 1974; 137: 143–144
   PubMed Web of Science ®Google Scholar
• Darby F. J., Grundy R. K., Price Evans D. A. Apparent Michaelis constants for the metabolism of [ureyl-14C]tolbutamide by human liver microsomal preparations. Biochemical Pharmacology 1972; 21: 407–414
   PubMed Web of Science ®Google Scholar
• Dixon M. The determination of enzyme inhibitor constants. Biochemical Journal 1953; 55: 170–171
   PubMed Web of Science ®Google Scholar
• Dixon M., Webb E. C. Enzymes. Academic, New York 1979
   Google Scholar
• Doecke C. J., Veronese M. E., Pond S. M., Miners J. O., Birkett D. J., Sansom L. N., McManus M. E. Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes. British Journal of Clinical Pharmacology 1991; 31: 125–130
   PubMed Web of Science ®Google Scholar
• Hofstee B. H. J. On the evaluation of constant Vm and Km in enzyme reactions. Science 1952; 116: 329–331
   PubMed Web of Science ®Google Scholar
• Holford N. H. G. MK MODEL Version 5,0. Biosoft, Cambridge 1994
   Google Scholar
• Hoskins J. M. Do anorectic agents inhibit CYP2D1-catalysed O-demethylation of dextromethorphan. Graduate Diploma in Science thesis. University of Sydney. 1994
   Google Scholar
• Kerry N. L., Somogyi A. A., Mikus G., Bochner F. Primary and secondary oxidative metabolism of dextromethorphan. Biochemical Pharmacology 1993; 45: 833–839
   PubMed Web of Science ®Google Scholar
• Kobayashi S., Murray S., Watson D., Sesardic D., Davies D. S., Boobis A. R. The specificity of inhibition of debrisoquine 4-hydroxylase activity by quinidine and quinine in the rat is the inverse of that in man. Biochemical Pharmacology 1989; 38: 2795–2799
   PubMed Web of Science ®Google Scholar
• Leemann T. D., Transon C., Bonnabry P., Dayer P. A major role for cytochrome P450TB (CYP2C subfamily) in the actions of non-steroidal antiinflammatory drugs. Drugs in Experimental and Clinical Research 1993; 5: 189–195
   Google Scholar
• McDaniel H. G., Podgainy H., Bressler R. The metabolism of tolbutamide in rat liver. Journal of Pharmacology and Experimental Therapeutics 1969; 167: 91–97
   PubMed Web of Science ®Google Scholar
• Meier P. J., Mueller H. K., Dick B., Meyer U. A. Hepatic monooxygenase activities in subjects with a genetic defect in drug oxidation. Gastroenterology 1983; 85: 682–693
   PubMed Web of Science ®Google Scholar
• Miners J. O., Smith K. J., Robson R. A., McManus M. E., Veronese M. E., Birkett D. J. Tolbutamide hydroxylation by human liver microsomes. Kinetic characterisation and relationship to other cytochrome P-450 dependent xenobiotic oxidations. Biochemical Pharmacology 1988; 37: 1137–1144
   PubMed Web of Science ®Google Scholar
• Oida T., Yoshida K., Kagemoto A., Sekine Y., Higashjima T. The metabolism of gliclazide in man. Xenobiotica 1985; 15: 87–96
   PubMed Web of Science ®Google Scholar
• Omura T., Sato R. The carbon monoxide binding pigment of liver microsomes. I. Evidence for its hemoprotein structure. Journal of Biological Chemistry 1964; 239: 2370–2378
   PubMed Web of Science ®Google Scholar
• Peart G. F., Boutagy J., Shenfield G. M. Lack of relationship between tolbutamide metabolism and debrisoquine oxidation phenotype. European Journal of Clinical Pharmacology 1987; 33: 397–402
   PubMed Web of Science ®Google Scholar
• Purba H. S., Back D. J., Orme M. L'E. Tolbutamide 4-hydroxylase activity of human liver microsomes: effect of inhibitors. British Journal of Clinical Pharmacology 1987; 24: 230–234
   PubMed Web of Science ®Google Scholar
• Rettie A. E., Korzekwa K. R., Kunze K. L., Lawrence R. F., Craig Eddy A., Aoyama T., Gelboin H. V., Gonzalez F. J., Trager W. F. Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions. Chemical Research and Toxicology 1992; 5: 54–59
   PubMed Web of Science ®Google Scholar
• Scott J., Poffenbarger P. L. Pharmacogenetics of tolbutamide metabolism in humans. Diabetes 1979; 28: 41–51
   PubMed Web of Science ®Google Scholar
• Tassaneeyakul W., Veronese M. E., Birkett D. J., Doecke C. J., McManus M. E., Sansom L. N., Miners J. O. Co-regulation of phenytoin and tolbutamide metabolism in humans. British Journal of Clinical Pharmacology 1992; 34: 494–498
   PubMed Web of Science ®Google Scholar
• Veronese M. E., Mackenzie P. I., Doecke C. J., McManus M. E., Miners J. O., Birkett D. J. Tolbutamide and phenytoin hydroxylation by cDNA-expressed human liver cytochrome P4502C9. Biochemical and Biophysical Research Communications 1991; 175: 1112–1118
   PubMed Web of Science ®Google Scholar
• Veronese M. E., McManus M. E., Laupattarakasem P., Miners J. O., Birkett D. J. Tolbutamide hydroxylation by human, rabbit and rat liver microsomes and by purified forms of cytochrome P-450. Drug Metabolism and Disposition 1990; 18: 356–361
   PubMed Web of Science ®Google Scholar